Co-Authors
This is a "connection" page, showing publications co-authored by Laura Atzori and Silvia Sanna.
Connection Strength
0.168
-
Safety of secukinumab treatment in COVID-19 affected psoriatic patients. Dermatol Ther. 2021 Jan; 34(1):e14710.
Score: 0.058
-
Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13722.
Score: 0.056
-
Successful guselkumab treatment in a psoriatic patient affected with Cornelia de Lange syndrome, and prosecution during the COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13433.
Score: 0.055